Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.

MLA

Mansouri, Abdellah, et al. “Sustained Activation of JNK/P38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells.” The Journal of Biological Chemistry, vol. 278, no. 21, May 2003, pp. 19245–56. EBSCOhost, https://doi.org/10.1074/jbc.M208134200.

APA

Mansouri, A., Ridgway, L. D., Korapati, A. L., Zhang, Q., Tian, L., Wang, Y., Siddik, Z. H., Mills, G. B., & Claret, F. X. (2003). Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. The Journal of Biological Chemistry, 278(21), 19245–19256. https://doi.org/10.1074/jbc.M208134200

Chicago

Mansouri, Abdellah, Lon D Ridgway, Anita L Korapati, Qingxiu Zhang, Ling Tian, Yibin Wang, Zahid H Siddik, Gordon B Mills, and François X Claret. 2003. “Sustained Activation of JNK/P38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells.” The Journal of Biological Chemistry 278 (21): 19245–56. doi:10.1074/jbc.M208134200.